# psoriasis - claude-opus-4-8

- Benchmark system: E2seq + Agent RAG
- Repeat: 3
- Task type: DISEASE-STATE
- Tissue / sample source: lesional skin
- Comparison or endpoint: psoriatic lesional skin versus normal control skin
- Answer input cohort: Discovery/Core only
- Selected items: 100
- Input fields: gene name, effect size (log2FC/HR), P value, FDR
- E2seq Agent RAG: enabled
- Conversation memory: disabled
- Thinking mode: disabled
- Held-out validation data in prompt/RAG: no
- Model API: Anthropic / claude-opus-4-8
- Message SHA-256: d1a33d3f606c81814c4fb94a6c63c8f1abebd3bde37d769e82eae4772d8ff873
- Response HTTP status: 200
- Prompt tokens: 28212
- Completion tokens: 9755
- Reasoning tokens: 0
- Total tokens: 37967
- API requests reported: 3
- Elapsed seconds: 274.901
- RAG status: reused_or_ready
- RAG records/genes reported: 100
- RAG elapsed seconds: 1150.303
- Question handoff seconds: 1163.566
- Final benchmark system: E2seq; file rank 3/5; original repeat 3; model vendor: Anthropic

---
# Multidimensional Interpretation of Psoriatic Lesional Skin Transcriptomics

## 1. Overall Biological Interpretation

The transcriptomic signature of psoriatic lesional skin reveals a coordinated immune-epidermal response dominated by hyperproliferation, barrier dysfunction, and sustained inflammatory signaling. The 90 upregulated genes versus 10 downregulated genes reflect an amplification cascade rather than a simple on/off switch, with massive fold changes (log2FC >11 for IL36A, DEFB4A/B) indicating pathological overactivation.

Three interconnected biological themes emerge: **IL-17/IL-36-driven inflammatory amplification**, **antimicrobial peptide overproduction and barrier remodeling**, and **aberrant keratinocyte differentiation with cornified envelope dysregulation**. These are not independent processes but rather a self-reinforcing loop where cytokine signaling drives keratinocyte hyperproliferation, which in turn produces more inflammatory mediators and structural proteins. The near-absence of downregulated genes and the extreme magnitude of upregulation suggest this is a system locked in a hyperactive state rather than a balanced regulatory response.

The molecular architecture aligns with established psoriasis pathophysiology: IL-36 and IL-17 family cytokines activate keratinocytes, which respond by producing antimicrobial peptides (defensins, S100 proteins), structural proteins (SPRR family, late cornified envelope proteins), and additional inflammatory mediators. The lipid metabolism enzymes (AKR1B10, FABP5) and gap junction proteins (GJB2, GJB6) point to altered epidermal differentiation and intercellular communication. The consistency with known psoriasis pathways (IL-17 signaling, cornified envelope formation) and the network-level coordination across multiple gene families provide strong internal coherence.

---

## 2. Core Biological Programs

### **Program 1: IL-36/IL-17 Cytokine Amplification Loop**

**Direction:** Upregulated  
**Major supporting genes:** IL36A (log2FC=11.37), IL36G (log2FC=5.68), IL19 (log2FC=7.58), IL20 (log2FC=5.67), TNIP3 (log2FC=7.28), ZC3H12A (log2FC=3.85)  
**Pathway:** IL-17 signaling pathway (KEGG), Cytokine-cytokine receptor interaction (KEGG)  

**Evidence:** Multiple IL-36 and IL-17 pathway cytokines show extreme upregulation with the highest fold changes in the dataset. IL36A and IL36G are directly involved in keratinocyte activation and neutrophil recruitment. IL19 and IL20, both IL-20 subfamily members, signal through shared receptors to amplify epidermal inflammation. TNIP3 and ZC3H12A are negative regulators of NF-κB and inflammatory signaling, and their upregulation represents a failed compensatory attempt to dampen the inflammatory response. The network topology shows IL1RAP connecting IL36A, IL36G, and IL36RN, confirming functional IL-36 receptor signaling. The magnitude of upregulation (>5 log2FC across multiple independent cytokines) and pathway enrichment provide convergent evidence.

**Strength and limitations:** Strong evidence from multiple independent cytokine family members, all showing massive upregulation with highly significant FDR values (<1e-70). The IL-17 and IL-36 pathways are validated therapeutic targets in psoriasis, supporting biological plausibility. Limitation: the dataset captures lesional skin at a single timepoint, so we cannot determine whether these cytokines are primary drivers or secondary amplifiers. The presence of negative regulators (TNIP3, ZC3H12A) suggests feedback mechanisms are activated but overwhelmed.

---

### **Program 2: Antimicrobial Peptide Storm and Innate Immune Hyperactivation**

**Direction:** Upregulated  
**Major supporting genes:** DEFB4A (log2FC=11.18), DEFB4B (log2FC=11.03), DEFB103A/B (log2FC=5.75), S100A12 (log2FC=8.33), PI3 (log2FC=9.24), TCN1 (log2FC=8.04)  
**Pathway:** Antimicrobial humoral response (GO:0019730), Staphylococcus aureus infection (KEGG)  

**Evidence:** β-defensins (DEFB4A, DEFB4B, DEFB103A/B) exhibit the most extreme upregulation in the cohort, reflecting a massive antimicrobial response. S100A12, a damage-associated molecular pattern (DAMP) protein, amplifies inflammation through RAGE receptor activation and neutrophil chemotaxis. PI3 (elafin/SKALP) and TCN1 (transcobalamin-1) are additional antimicrobial effectors massively elevated in psoriatic lesions. The coordinated upregulation of multiple defensin genes and the network evidence showing CCR6 connecting DEFB103A, DEFB4A, and DEFB4B indicate a coherent antimicrobial program. The pathway enrichment for Staphylococcus aureus infection reflects the known colonization of psoriatic plaques and the host response.

**Strength and limitations:** Strong evidence from multiple independent antimicrobial genes spanning defensins, S100 proteins, and serine protease inhibitors, all showing log2FC >5 and FDR <1e-68. The antimicrobial response is a hallmark of psoriatic epidermis and directly measurable at the protein level. Limitation: antimicrobial peptides are both protective (clearing pathogens) and pro-inflammatory (activating immune cells), so this program represents both an appropriate host defense and a pathological amplification cycle. The causal direction—whether microbial colonization drives AMP production or AMP dysregulation promotes colonization—cannot be resolved from this cross-sectional data.

---

### **Program 3: Cornified Envelope Dysregulation and Aberrant Keratinization**

**Direction:** Upregulated  
**Major supporting genes:** SPRR2A (log2FC=7.31), SPRR2B (log2FC=6.38), SPRR2D (log2FC=5.92), SPRR2E (log2FC=3.99), SPRR3 (log2FC=7.18), LCE3A, LCE3D, KRT6A (log2FC=4.30)  
**Pathway:** Formation of the cornified envelope (Reactome R-HSA-6809371), Epidermis development (GO:0008544)  

**Evidence:** Small proline-rich proteins (SPRR2A/B/D/E, SPRR3) are structural components of the cornified envelope that cross-link to form the outermost barrier. Their massive upregulation indicates hyperactive terminal differentiation. Late cornified envelope (LCE) genes and KRT6A, a stress-induced keratin, further support aberrant keratinization. Network analysis shows SPRR1B connecting 8 selected genes (KRT6A, SPRR2A/B/D/E) and SPRR2B connecting 6 genes (LCE3A/D, SPRR2D/E/F), confirming functional coordination. The Reactome pathway "Formation of the cornified envelope" directly captures 12 genes from this dataset. The fold changes (log2FC 4–7) are substantial but lower than cytokines and AMPs, suggesting this is a downstream consequence of inflammatory signaling.

**Strength and limitations:** Strong evidence from multiple SPRR family members and network-level coordination. The cornified envelope is a measurable histological feature in psoriasis (hyperkeratosis, parakeratosis). Limitation: SPRR upregulation is a stereotyped response to epidermal stress and is not specific to psoriasis—similar patterns occur in other inflammatory dermatoses and wound healing. The causal relationship to disease pathology is indirect: these structural changes contribute to plaque thickness and scaling but are secondary to upstream immune dysregulation.

---

### **Program 4: Lipid Metabolism Reprogramming and Barrier Lipid Disruption**

**Direction:** Upregulated (AKR1B10, AKR1B15, FABP5, PLA2G4D); Downregulated (BTC, CYP2W1)  
**Major supporting genes:** AKR1B10 (log2FC=6.27), AKR1B15 (log2FC=5.23), FABP5 (log2FC=3.65), PLA2G4D (log2FC=4.62), ABCG4 (log2FC=4.75) | BTC (log2FC=-4.30), CYP2W1 (log2FC=-4.70)  
**Pathway:** Arachidonic acid metabolism (inferred from PLA2G4D), Fatty acid binding (inferred from FABP5)  

**Evidence:** AKR1B10 and AKR1B15 (aldo-keto reductases) metabolize lipid aldehydes and retinoids, critical for epidermal differentiation and lipid barrier integrity. FABP5 (fatty acid-binding protein 5) transports fatty acids and retinoids into keratinocyte nuclei, where it activates PPARβ/δ signaling to drive hyperproliferation. PLA2G4D (phospholipase A2 group IVD) releases arachidonic acid for eicosanoid synthesis. ABCG4, a cholesterol transporter, is upregulated, potentially reflecting altered lipid efflux. Conversely, BTC (betacellulin, an EGFR ligand) and CYP2W1 (cytochrome P450 involved in fatty acid metabolism) are downregulated, suggesting disrupted lipid homeostasis. The bidirectional changes and the functional diversity (lipid oxidation, transport, signaling) indicate a broad reprogramming of lipid metabolism rather than a single pathway.

**Strength and limitations:** Moderate evidence. Multiple lipid-related genes are dysregulated, but they span different pathways (reductases, binding proteins, phospholipases, transporters), making it harder to define a unified program. AKR1B10 and FABP5 are well-studied in psoriasis and keratinocyte biology, providing biological plausibility. Limitation: lipid metabolism is complex and context-dependent; these changes could reflect compensatory responses to barrier damage rather than primary drivers. The downregulated genes (BTC, CYP2W1) have limited mechanistic characterization in skin, weakening the interpretation. Additional lipidomic data would be needed to confirm functional consequences.

---

### **Program 5: Chemokine Signaling and Leukocyte Trafficking**

**Direction:** Upregulated  
**Major supporting genes:** CXCL13 (log2FC=5.89), GPR15LG (log2FC=5.52), HPSE (log2FC=2.92), WNT5A (log2FC=2.53)  
**Pathway:** Cytokine-cytokine receptor interaction (KEGG), Chemokine signaling pathway (KEGG, inferred)  

**Evidence:** CXCL13 is a B cell-attracting chemokine typically associated with tertiary lymphoid structures, suggesting organized immune infiltration in chronic psoriatic lesions. GPR15LG (GPR15 ligand) recruits GPR15+ T cells, which are enriched in skin-homing memory populations. HPSE (heparanase) degrades extracellular matrix heparan sulfate, facilitating leukocyte extravasation and cytokine release. WNT5A, a non-canonical Wnt ligand, promotes keratinocyte proliferation and inflammatory signaling. These genes collectively support leukocyte recruitment and tissue remodeling. The fold changes are moderate (log2FC 2.5–5.9), consistent with chemokine signaling being a more regulated, dose-dependent process compared to structural proteins or AMPs.

**Strength and limitations:** Moderate evidence. CXCL13 upregulation is well-documented in chronic inflammatory skin diseases and indicates B cell involvement beyond the classical T cell paradigm of psoriasis. GPR15LG is emerging as a skin-specific chemokine. Limitation: only a few chemokines are represented in the top 100 genes, and the classical psoriasis chemokines (CXCL1, CXCL8, CCL20) are absent from this list, suggesting they may have been just below the selection threshold or already captured in previous analyses. HPSE and WNT5A have pleiotropic functions beyond chemotaxis, diluting the specificity of this program. This program is the weakest of the five in terms of gene number and mechanistic coherence.

---

## Summary

The five programs represent distinct but interconnected layers of psoriasis pathobiology: cytokine amplification drives the system, antimicrobial overproduction and aberrant keratinization are downstream keratinocyte responses, lipid metabolism reprogramming reflects barrier dysfunction, and chemokine signaling sustains immune infiltration. The strongest programs (1–3) are supported by multiple independent genes, extreme fold changes, validated pathways, and network evidence. Programs 4–5 are more diffuse but still biologically relevant. The primary limitation across all programs is the cross-sectional design—we observe the fully developed lesional state but cannot distinguish initiating events from self-perpetuating consequences.

E2seq statistical audit: selected=100, ledger=100, RAG records=100, numeric claims checked=31, external claims checked=0, external mismatches=0, status=needs review.

Answer model API: Anthropic / claude-opus-4-8

Source coverage (gene sources = selected items with records / selected RAG items; literature sources = articles / queries)
Online APIs: alliance 91/100 selected items (records returned); cbioportal 91/100 selected items (records returned); chembl 11/100 selected items (partially returned; some queries failed); civic 4/100 selected items (records returned); clinicaltrials 40/100 selected items (records returned); clinvar 90/100 selected items (records returned); ensembl 44/100 selected items (partially returned; some queries failed); europepmc 848 articles / initial full-cohort RAG 100 queries + 4 current-round queries; gtex 83/100 selected items (records returned); gwas 100/100 selected items (records returned); hpa 76/100 selected items (records returned); humanbase 100/100 selected items (records returned); intact 79/100 selected items (records returned); mygene 100/100 selected items (records returned); omnipath 36/100 selected items (records returned); opentargets 90/100 selected items (records returned); pubmed 669 articles / initial full-cohort RAG 100 queries + 3 current-round queries; quickgo 80/100 selected items (records returned); reactome 100/100 selected items (records returned); uniprot 80/100 selected items (records returned)
Local databases: gutmgene 2/100 selected items (records returned); hmdb 25/100 selected items (records returned); string 78/100 selected items (records returned); trrust 17/100 selected items (records returned)
